Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastroenterology
•
Stomach Disorders
How do you manage a patient who is reliant on NSAIDs for arthritis but has developed PUD?
Would you consider COX-2 selective inhibition, PPI, PCAB, or some combination thereof?
Related Questions
How do you approach the management of patients who require nutritional restoration in the setting of a presumed functional GI disorder recalcitrant to behavioral medicine and pharmacologic therapies?
What is your approach to choosing a particular advanced therapy based on patient or disease factors when initiating treatment for moderate-severe IBD?
What pharmacologic therapies do you use to treat alcohol use disorder in a patient with cirrhosis?
How you do approach treatment for a patient with active seropositive RA (+RF/+CCP) who is receiving treatment for Hepatitis C?
How would you approach additional workup and management of a patient with active Crohn’s disease, who has multiple lung and brain nodules, with lung pathology demonstrating necrotizing granulomatous inflammation and brain biopsy with granulomatous inflammation and medium-large vessel vasculitis?
How long should surgery be delayed in a patient with localized, resectable pancreatic cancer who developed acute pancreatitis following EUS guided biopsy?
Does hepatitis B vaccination reduce the risk of HBV reactivation associated with immunosuppressive therapy?
Do you avoid JAK inhibitors in patients with a history of liver disease including NAFLD or cirrhosis?
How do you practically approach a tailored elimination diet in young patients with numerous food impactions and esophageal strictures who are intermittently compliant with PPI or topical steroids?
When would you phlebotomize patients with secondary hemochromatosis, such as due to NAFLD/cirrhosis?